News

  • Customer Notification: Change in Screening assay for Mumps IgM and Measles IgM antibodies

    Aug
    29

    The NVRL is pleased to notify users that following a successful verification Liaison™ Measles IgM and Liaison™ Mumps IgM assays are to be introduced as screening assays for blood samples from Monday 4th September 2023.

    The current Microimmune™ assays for these infection markers will no longer be in use.

     

    The wording on NVRL reports after this date will reflect this change.

     

    Any queries in relation to this notification should be addressed to the Clinical Team on 01-7164401.

     

    CN-23-18

     

    Posted By Helen.Dawkins read more

  • Customer Notification: Serodia T pallidum TPPA test is no longer available - replacement TPHA test is being introduced

    Aug
    22

    NVRL has been notified that the Serodia TPPA Treponema pallidum Particle Agglutination assay is no longer available.


    NVRL is delighted to inform its users that an alternative assay has been identified, the NewBio TPHA Treponema pallidum Haemagglutination assay, and following a
    successful verification is to be introduced as of Monday 28th August 2023.


    The NVRL User Manual will be updated in due course to reflect this change.

    Posted By Helen.Dawkins read more

  • Cessation of Service at NSLB - NVRL Satellite Laboratory Back Weston

    Jun
    29

     

    Cessation of NSLB Laboratory Service – 30th June 2023           

    Users of the NSLB, the NVRL Satellite Laboratory based at Back Weston Campus for SARS-CoV-2 testing, will be aware that this laboratory is closing from tomorrow 30th June 2023. 

    Posted By Helen.Dawkins read more

  • On call telecoms planned maintenance 25 May 21:30-22:00

    May
    25

    We have received notification from our Telecoms provider Arema Connect that there will need to be emergency planned maintenance their network on the 25th May from 21.30 to 22.00. During this period it may not be possible to contact the NVRL for urgent investigations through this route. Therefore, between 21.30 to 22.00 if urgent testing is required please contact 0879806448.

    Reference: CN-23-11

    Posted By Brian O'Grady read more

  • Change in Syphilis RPR assay to Fortress RPR

    May
    16

    The NVRL has been notified that the Axis Shield T. pallidum RPR assay is no longer available.

    NVRL is delighted to inform its users that an alternative assay has been identified, the Fortress RPR assay, and following a successful verification is to be introduced as of Tuesday 16th May 2023.

     


    Any queries in relation to this notification should be addressed to the Clinical Team on 01-7164401.

    Reference: CN-23-8

    Posted By Helen.Dawkins read more

  • Infographic and Video in relation to National Serosurveillance Programme

    Mar
    21
    At the request of the Health Protection Surveillance Centre, HPSC, NVRL is pleased to share the infographic and video prepared in relation to the National Serosurveillance Programme. 
    I have included the link to the video here. https://youtu.be/YjUXVZdZOAc
    Posted By Helen.Dawkins read more

  • Change in NVRL Mycoplasma pneumoniae testing

    Feb
    25

    Change in NVRL Mycoplasma pneumoniae testing

     – implementation date 6th March 2023

     

    NVRL is delighted to inform our users that as of 6th March 2023 we will be investigating serum samples requesting Mycoplasma pneumoniae for IgM and IgG antibodies.

    Posted By Helen.Dawkins read more

  • Change in NVRL Hepatitis E screening: UPDATE – implementation date 6th March 2023

    Feb
    21

    HEPATITIS E Screening at NVRL

     

    NVRL previously notified our users that we are replacing the Fortress HEV IgM assay in favour of Diasorin Liaison XL HEV IgM assay and also introducing a supplementary second line Vidas HEV IgM assay to confirm Diasorin reactive samples.

    This change was delayed due to supply issues, which have now been resolved. NVRL is very pleased to advise customers that this change will be implemented from 6th March 2023.

    Posted By Helen.Dawkins read more

  • Hepatitis E IgM serology update

    Dec
    01

    NVRL has just been notified of manufacturer supply issues with the BioMerieux Vidas HEV IgM assay. Due to factors beyond our control the implementation of the Liaison HEV IgM assay and supplementary second line Vidas HEV IgM will be delayed. We will issue further updates as available.

    CN-22-20

    Posted By Brian O'Grady read more

  • Change in NVRL Hepatitis E screening: UPDATE to be introduced 28th November 2022

    Nov
    21

    NVRL is replacing the Fortress HEV IgM assay in favour of Diasorin Liaison XL HEV IgM assay and also introducing a supplementary second line Vidas HEV IgM assay to confirm Diasorin reactive samples.

    The Diasorin and Vidas HEV IgM assays have comparable sensitivity. However, by using two assays in combination, we can generate improved specificity in comparison with Fortress HEV IgM alone, whilst also allowing for increased automation.

    NVRL IT department will provide specific information including relevant test request codes.

    Posted By Helen.Dawkins read more